Effect of Enhanced Feedback to Hospitals in an Emerging Clinical Information Network
NCT ID: NCT02817971
Last Updated: 2017-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
900 participants
INTERVENTIONAL
2016-03-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Nurse-based Care Coordination on Readmissions Among Primary Care Patients: a Stepped Wedge Cluster Randomized Trial
NCT04224220
Parents' Health-Education Handbook in Preventing Pediatric Urolithiasis Formation
NCT04284241
Knowledge Mobilization Activities to Support Decision-Making by Youth, Parents and Adults: Study Protocol
NCT05358990
45 Minutes Vs. Three Hours Educational Intervention on Communication and Play for Paediatric Healthcare Professionals
NCT06859632
Does Teaching Before or After Simulation Improve Learning?
NCT06092320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hospitals were randomized to receive either enhanced feedback (n = 6 hospitals) or standard feedback (n = 6 hospitals) delivered over a six-month period following nationwide pneumonia treatment policy change. The primary outcome is the proportion of all pneumonia admissions (fulfilling criteria for treatment with oral amoxicillin) who are correctly classified and treated using new guideline recommendations. The proportion of treatment change from oral amoxicillin to alternative antibiotics for pneumonia (considered a proxy measure of treatment failure) will be reported as a secondary outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced feedback
1. Monthly written feedback incorporating goal setting, and action planning delivered by a senior clinical coordinator for selected pneumonia indicators
2. Two-monthly written feedback on multiple quality of paediatric care indicators
3. Clinical network promoting clinical leadership linked to mentorship and peer to peer support
4. Improved use of health information on service delivery
Enhanced feedback
Hospital level feedback delivered every month through paediatrician on the level of adherence to revised pneumonia treatment recommendations.
Standard feedback
1. Two-monthly written feedback on multiple quality of paediatric care indicators
2. Clinical network promoting clinical leadership linked to mentorship and peer to peer support
3. Improved use of health information on service delivery
Standard feedback
Hospital level feedback delivered every two months through paediatrician on the performance of multiple paediatric care indicators for managing severely ill children.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced feedback
Hospital level feedback delivered every month through paediatrician on the level of adherence to revised pneumonia treatment recommendations.
Standard feedback
Hospital level feedback delivered every two months through paediatrician on the performance of multiple paediatric care indicators for managing severely ill children.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* children presenting with pneumonia and tuberculosis or cough lasting more than 2 weeks, or severe malaria
2 Months
59 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KEMRI-Wellcome Trust Collaborative Research Program
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mike English, MD
Role: PRINCIPAL_INVESTIGATOR
KEMRI-Wellcome Trust Research Priogramme
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kerugoya County Hospital
Kerugoya, Kerugoya, Kenya
Busia County Hospital
Busia, , Kenya
Embu County Hospital
Embu, , Kenya
Kakamega County Referral Hospital
Kakamega, , Kenya
Vihiga County Hospital
Kakamega, , Kenya
Karatina County Hospital
Karatina, , Kenya
Kiambu County Hospital
Kiambu, , Kenya
Kisumu County Hospital
Kisumu, , Kenya
Kitale County Hospital
Kitale, , Kenya
Machakos County Hospital
Machakos, , Kenya
Mama Lucy Kibaki Hospital
Nairobi, , Kenya
Nyeri County Hospital
Nyeri, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ayieko P, Irimu G, Ogero M, Mwaniki P, Malla L, Julius T, Chepkirui M, Mbevi G, Oliwa J, Agweyu A, Akech S, Were F, English M; Clinical Information Network Authors. Effect of enhancing audit and feedback on uptake of childhood pneumonia treatment policy in hospitals that are part of a clinical network: a cluster randomized trial. Implement Sci. 2019 Mar 4;14(1):20. doi: 10.1186/s13012-019-0868-4.
Ayieko P, Irimu G, English M. Effect of enhanced feedback to hospitals that are part of an emerging clinical information network on uptake of revised childhood pneumonia treatment policy: study protocol for a cluster randomized trial. Trials. 2017 Sep 7;18(1):416. doi: 10.1186/s13063-017-2152-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEMRI_CT_2016\0021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.